Profile
Dr Colas studied molecular biology at the University of Lyon and At the end of 1993, he joined the laboratory of Roger Brent, at the Department of Molecular Biology of Massachusetts General Hospital (Harvard Medical School, Boston, USA), where he contributed to the development of the peptide aptamer technology.
Dr Colas was recruited by the INSERM and came back to Lyon in 1998 to join Dr Rudkin's lab.
He pursued his work on peptide aptamer technologies.
In 2002, Dr Colas took a leave from the INSERM to become Scientific Director of Aptanomics.
Former positions of Pierre Colas
| Companies | Position | End |
|---|---|---|
Aptanomics SA
Aptanomics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures novel therapeutics | Chief Tech/Sci/R&D Officer | 24/01/2008 |
Training of Pierre Colas
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Aptanomics SA
Aptanomics SA Pharmaceuticals: MajorHealth Technology Develops and manufactures novel therapeutics | Health Technology |
Ecole Centrale Lyon
Ecole Centrale Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
École Normale Supérieure de Lyon
École Normale Supérieure de Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Pierre Colas
















